Risks

Extremely weak liquidity, with a 0.16 current ratio and 0.13 quick ratio, leaves IBO far more exposed to working-capital stress than most peers.

Negative interest coverage of -19.5x means operating earnings do not support financing costs, increasing refinancing and dilution risk versus better-covered peers.

A 1,706-day cash conversion cycle, driven by 2,054 days of receivables, signals severe cash lock-up that materially constrains growth and recovery versus peers.

Minimal net debt to EBITDA masks balance-sheet fragility because the company appears to rely on non-debt funding, unlike peers with more normal liquidity buffers.

Payables stretched to 402 days may temporarily support cash, but it also suggests supplier pressure and weaker commercial terms than peers with healthier cycles.

Opportunities

If receivables normalize, the unusually large cash conversion cycle could release meaningful cash, creating more upside than peers with already efficient working capital.

Low reported net debt to EBITDA gives IBO more room than leveraged peers to stabilize operations if cash generation improves and liquidity pressure eases.

Any improvement in collections would have outsized impact because the current receivables burden is so large relative to peers, amplifying incremental working-capital gains.

Overall Score

IBO’s forward positioning is dominated by severe liquidity and cash-conversion stress that outweighs limited upside from working-capital normalization and low reported net debt.